Asymchem Life Science (Tianjin) Co., Ltd
HighTianjin, China
GMP
Tianjin unit of Asymchem, a CDMO listed in Shenzhen and Hong Kong that makes peptides and oligos; US DMFs for liraglutide and semaglutide.
- Model
- CDMO
- Manufacturer?
- Yes
Liraglutide API manufacturers
Liraglutide is a GLP-1 receptor agonist; the active ingredient of Victoza and Saxenda.
20 listed companies hold an active US Type II Drug Master File for Liraglutide API, based in China (8), India (7), Switzerland (2), United States (1), Taiwan (1), Italy (1). 14 have a regulator record of GMP manufacturing, and 1 carries an open FDA warning letter.
Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.
Liraglutide API DMF holders (20)
Source: FDA Drug Master File list. Holding a DMF is a regulatory filing, not an FDA approval.
Auro Peptides Ltd
HighSangareddy (near Hyderabad), India
GMP
Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
- Model
- CDMO
- Manufacturer?
- Yes
Biocon Ltd
HighBengaluru, India
GMP
Bengaluru biopharma company that makes generic APIs and complex formulations, including GLP-1 peptides. Holds US DMFs for liraglutide, semaglutide and tirzepatide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Piramal Pharma Ltd (Piramal Pharma Solutions)
HighNavi Mumbai, India
GMP
Indian CDMO whose Turbhe, Navi Mumbai site develops and makes peptide APIs by solid- and solution-phase synthesis. Holds US DMFs for 9 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
Shilpa Pharma Lifesciences Ltd
HighRaichur, India
GMP
Raichur API and CDMO subsidiary of Shilpa Medicare; US DMFs for desmopressin, liraglutide and octreotide; Raichur units inspected by US FDA in 2025.
- Model
- CDMO
- Manufacturer?
- Yes
Sinopep-Allsino Biopharmaceutical Co., Ltd.
HighLianyungang, Jiangsu, China
GMP
Jiangsu peptide CDMO and generic API supplier with large automated SPPS capacity; states it has passed four US FDA inspections. Holds US DMFs for 9 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
AmbioPharm
HighNorth Augusta, South Carolina, USA
GMPCOA
US peptide API CDMO with facilities in the US and China.
- Model
- CDMO
- Manufacturer?
- Yes
Bachem Holding AG
HighBubendorf, Switzerland
GMPCOA
Swiss peptide and oligonucleotide CDMO with GMP plants in Europe and the US.
- Model
- CDMO
- Manufacturer?
- Yes
Hybio Pharmaceutical
HighShenzhen, China
GMP
Chinese peptide drug manufacturer producing APIs and finished products.
- Model
- Manufacturer
- Manufacturer?
- Yes
PolyPeptide Group
HighBaar, Switzerland (sites in SE, BE, FR, US, IN)
GMPCOA
Peptide-focused CDMO running GMP manufacturing sites on three continents.
- Model
- CDMO
- Manufacturer?
- Yes
ScinoPharm Taiwan
HighTainan, Taiwan
GMP
API manufacturer and CDMO focused on complex generics, including peptides.
- Model
- CDMO
- Manufacturer?
- Yes
ALP Pharm Beijing Co., Ltd.
HighBeijing, China
Beijing API company, founded 2006, that holds DMFs and has its APIs made in partner facilities under its own quality control. Holds US DMFs for 13 peptide APIs.
- Model
- Manufacturer
- Manufacturer?
- Yes
Chongqing Chen'an Biopharmaceutical Co., Ltd
HighChongqing, China
Chongqing maker of diabetes and obesity drugs, active since 2015 and controlled by Zhifei (300122) since 2025; US DMFs for liraglutide and semaglutide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Fresenius Kabi iPSUM S.r.l.
HighVilladose (Rovigo), Italy
Fresenius Kabi's Italian API unit; its Villadose site near Venice develops and makes peptide APIs, also offered through Fresenius Kabi contract manufacturing. Holds US DMFs for 6 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
Hangzhou Jiuyuan Gene Engineering Co., Ltd
HighHangzhou, China
Hangzhou recombinant drug maker listed in Hong Kong (02566), formerly Huadong Medicine's gene engineering centre; US DMF for liraglutide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Hemmo Pharmaceuticals Pvt Ltd (Piramal Pharma Solutions)
HighNavi Mumbai, India
GMP
Mumbai peptide API maker acquired by Piramal Pharma in 2021; its oxytocin API is WHO-prequalified; US DMF for oxytocin.
- Model
- CDMO
- Manufacturer?
- Yes
Shenzhen JYMed Technology Co., Ltd. (JYMed Peptide)
HighShenzhen, China
GMP
Shenzhen peptide CDMO and API maker founded in 2009, with 13 cGMP lines and 85,000 L of SPPS/LPPS reactor volume. Holds US DMFs for 6 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
High
Suzhou peptide API and formulation maker founded in 2000, flagship of Tianma Pharma Group, offering CRO/CMO/CDMO services. Holds US DMFs for 8 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
Reliance Life Sciences Pvt Ltd
MediumNavi Mumbai, India
Navi Mumbai biopharma and specialty pharma company; US DMFs for lanreotide and liraglutide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Sun Pharmaceutical Industries Ltd
LowMumbai, India
GMP
Mumbai-based generics group that makes APIs and finished medicines. Holds US Type II DMFs for 15 peptide APIs, including GLP-1s and GnRH analogues.
Notice: open regulatory issue
- Model
- Manufacturer
- Manufacturer?
- Yes
Other peptide APIs
- Semaglutide API manufacturers (45)
- Tirzepatide API manufacturers (28)
- Octreotide API manufacturers (20)
- Icatibant API manufacturers (13)
- Leuprolide API manufacturers (12)
- Cetrorelix API manufacturers (11)
- Teriparatide API manufacturers (11)
- Desmopressin API manufacturers (10)
- Retatrutide API manufacturers (10)
- Lanreotide API manufacturers (9)
- Linaclotide API manufacturers (9)
- Bivalirudin API manufacturers (8)
- Difelikefalin API manufacturers (8)
- Eptifibatide API manufacturers (8)
- Ganirelix API manufacturers (8)
- Bortezomib API manufacturers (7)
- Degarelix API manufacturers (7)
- Oxytocin API manufacturers (7)
- Vasopressin API manufacturers (7)
- Glatiramer API manufacturers (6)
- Calcitonin API manufacturers (5)
- Carfilzomib API manufacturers (5)
- Caspofungin API manufacturers (5)
- Exenatide API manufacturers (5)
- Micafungin API manufacturers (5)
- Plecanatide API manufacturers (5)
- Etelcalcetide API manufacturers (4)
- Sincalide API manufacturers (4)
- Glucagon API manufacturers (3)
Related
Frequently asked questions
Who manufactures Liraglutide API?
Companies holding active US DMFs for Liraglutide include Asymchem Life Science (Tianjin) Co., Ltd, Auro Peptides Ltd, Biocon Ltd, Piramal Pharma Ltd (Piramal Pharma Solutions), Shilpa Pharma Lifesciences Ltd, Sinopep-Allsino Biopharmaceutical Co., Ltd., AmbioPharm, Bachem Holding AG, Hybio Pharmaceutical, PolyPeptide Group and 10 more. Other manufacturers may supply it without a US DMF.
Where are Liraglutide API manufacturers based?
Among listed DMF holders: China (8), India (7), Switzerland (2), United States (1), Taiwan (1), Italy (1).
Do any Liraglutide API holders have FDA warning letters?
Sun Pharmaceutical Industries Ltd has an open FDA warning letter, shown on the listing and in the FDA enforcement tracker.
Does a DMF mean the API is FDA approved?
No. FDA reviews a DMF when a drug application references it and does not approve DMFs on their own.